Yang DH - Search Results

1

Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II.

Lu Q, Wang L, Zhang JY, Yang DH. Lu Q, et al. Among authors: yang dh. Front Oncol. 2023 Mar 10;13:1164399. doi: 10.3389/fonc.2023.1164399. eCollection 2023. Front Oncol. 2023. PMID: 36968996 Free PMC article. No abstract available.

2

METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.

Wu S, Wang H, Yang Q, Liu Z, Du J, Wang L, Chen S, Lu Q, Yang DH. Wu S, et al. Among authors: yang q, yang dh. Cancer Lett. 2024 Aug 10;597:217058. doi: 10.1016/j.canlet.2024.217058. Epub 2024 Jun 14. Cancer Lett. 2024. PMID: 38880226

3

Editorial: ABC transporters and drug resistance.

Lu Q, Ambudkar SV, Yang DH. Lu Q, et al. Among authors: yang dh. Drug Resist Updat. 2024 Nov;77:101135. doi: 10.1016/j.drup.2024.101135. Epub 2024 Aug 10. Drug Resist Updat. 2024. PMID: 39178712 No abstract available.

4

Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy.

Xia X, Yang Z, Lu Q, Liu Z, Wang L, Du J, Li Y, Yang DH, Wu S. Xia X, et al. Among authors: yang dh, yang z. Mol Cancer. 2024 Aug 26;23(1):175. doi: 10.1186/s12943-024-02079-8. Mol Cancer. 2024. PMID: 39187850 Free PMC article. Review.

5

The pharmacological effects and safety of the raw and prepared folium of Epimedium brevicornu Maxim. on improving kidney-yang deficiency syndrome and sexual dysfunction.

Wang K, Li J, Zheng X, Xu J, Wang Z, Li S, Yang Q, Wu Y, Yang DH, Yao S, Zheng X. Wang K, et al. Among authors: yang q, yang dh. Front Pharmacol. 2023 Jul 14;14:1233468. doi: 10.3389/fphar.2023.1233468. eCollection 2023. Front Pharmacol. 2023. PMID: 37521477 Free PMC article.

6

Unraveling immunotherapy's role in propelling cancer outcomes.

Ji N, Tiwari AK, Yang DH. Ji N, et al. Among authors: yang dh. Cancer Rep (Hoboken). 2023 Jul;6(7):e1862. doi: 10.1002/cnr2.1862. Epub 2023 Jul 6. Cancer Rep (Hoboken). 2023. PMID: 37409510 Free PMC article. No abstract available.

7

Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies.

Huang Y, Qin Y, He Y, Qiu D, Zheng Y, Wei J, Zhang L, Yang DH, Li Y. Huang Y, et al. Among authors: yang dh. Drug Resist Updat. 2024 May;74:101082. doi: 10.1016/j.drup.2024.101082. Epub 2024 Mar 26. Drug Resist Updat. 2024. PMID: 38569225 Free article. Review.

8

Current therapy and drug resistance in metastatic castration-resistant prostate cancer.

Cai M, Song XL, Li XA, Chen M, Guo J, Yang DH, Chen Z, Zhao SC. Cai M, et al. Among authors: yang dh. Drug Resist Updat. 2023 May;68:100962. doi: 10.1016/j.drup.2023.100962. Epub 2023 Apr 14. Drug Resist Updat. 2023. PMID: 37068396 Free article. Review.

9

Multi-omics dissection of stage-specific artemisinin tolerance mechanisms in Kelch13-mutant Plasmodium falciparum.

Chen J, Gao P, Xiao W, Cheng G, Krishna S, Wang J, Wong YK, Wang C, Gu L, Yang DH, Wang J. Chen J, et al. Among authors: yang dh. Drug Resist Updat. 2023 Sep;70:100978. doi: 10.1016/j.drup.2023.100978. Epub 2023 Jun 2. Drug Resist Updat. 2023. PMID: 37385107

10

CAR T-Cell therapy for the management of mantle cell lymphoma.

Huang Z, Chavda VP, Bezbaruah R, Dhamne H, Yang DH, Zhao HB. Huang Z, et al. Among authors: yang dh. Mol Cancer. 2023 Mar 31;22(1):67. doi: 10.1186/s12943-023-01755-5. Mol Cancer. 2023. PMID: 37004047 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,667 results

Search Page

Filters